Xianjian Q. Wu
Baise City, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Retraction notice to "METTL3 alters AK3 RNA expression in an m6A-dependent manner to affect the proliferation and metastasis of hepatocellular carcinoma" [Int. J. Biol. Macromol. 282 (2024) 137213].
Journal: International journal of biological macromolecules
Published: August 12, 2026
Retraction notice to "PAARH promotes M2 macrophage polarization and immune evasion of liver cancer cells through VEGF protein" [Int. J. Biol. Macromol. 281 (2024) 136580].
Journal: International journal of biological macromolecules
Published: July 21, 2026
METTL3 alters AK3 RNA expression in an m6A-dependent manner to affect the proliferation and metastasis of hepatocellular carcinoma.
Journal: International journal of biological macromolecules
Published: September 20, 2024
PAARH promotes M2 macrophage polarization and immune evasion of liver cancer cells through VEGF protein.
Journal: International journal of biological macromolecules
Published: August 29, 2024
Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway.
Journal: Open medicine (Warsaw, Poland)
Published: June 04, 2024
LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: November 09, 2023
METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2.
Journal: Scientific reports
Published: November 06, 2023
HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way.
HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way.
Journal: Molecular medicine reports
Published: May 09, 2023
N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC.
Journal: Journal of hepatocellular carcinoma
Published: April 01, 2023
LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: February 16, 2023
Hypoxia-induced Fascin-1 upregulation is regulated by Akt/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and Hippo/YAP activation.
Journal: Cell death discovery
Published: August 28, 2021
Last Updated: 09/26/2026